Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 2Terminated 1Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 108Breast 76Thoracic 37Gynecologic 20Head & Neck 14Tumor-Agnostic 13Genitourinary 13Dermatologic 12Sarcoma 6Other solid neoplasm 3CNS 3Other neoplasm 1Other hematologic neoplasm 1Lymphoid 1

Conditions

Tongue Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Precancerous Conditions 1Papillomavirus Infections 1Head and Neck Neoplasms 1

Interventions

Biopsy 8Polymerase Chain Reaction 6Peripheral Blood Stem Cell Transplantation 5Epoetin Alfa 5Surveys and Questionnaires 4Sulindac 4Microarray Analysis 4Gene Expression Profiling 4Early Intervention, Educational 4Cyclophosphamide 4Colposcopy 4Cisplatin 4Cetuximab 4Celecoxib 4fludarabine phosphate 3Vaginal Smears 3Selenium 3Pemetrexed 3Methotrexate 3Imiquimod 3Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 3Eflornithine 3Darbepoetin alfa 3Aspirin 3Antilymphocyte Serum 3Whole-Body Irradiation 2Vitamin E 2Videotape Recording 2Tacrolimus 2Radiotherapy, Intensity-Modulated 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Albumin-Bound Paclitaxel × Other neoplasm × Clear all
NCT01084083 2023-06-28

Induction Chemotherapy Followed By Cetuximab and Radiation in HPV-Associated Resectable Stage III/IV Oropharynx Cancer

Eastern Cooperative Oncology Group

Phase 2 Completed
90 enrolled 7 charts
Head & NeckOther neoplasm

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Precancerous Conditions, Tongue Neoplasms, Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡